The E.W. Scripps Company will report fourth-quarter 2024 operating results after the markets close on Thursday, Feb. 27. The call with the company's senior management team will take place at 9:30 a.m.

Students from around the world saw their space-themed works of pen, paint, and poetry floating in the cupola of the International Space Station (ISS) as part of a contest to spark student interest in ...

Finally, eligibility criteria for HC participants included: (1) no lifetime diagnosis of a DSM-5 disorder except for simple/specific phobias; (2) age of 60 years or older; (3) MADRS score of 10 or ...

Tracking lipid variability may be a reliable method of predicting dementia and cognitive decline among community-dwelling older adults, according to new research from Neurology. Senators grilled ...

A new company is making hay from an R&D shift at Denali Therapeutics, acquiring several of its neuroscience drug candidates and raising money from one of its original investors. The biotech ...

as well as SAGE-324 in essential tremor and other neurological disorders. The blockbuster deal featured an upfront payment of $875 million from Biogen and a $650 million equity investment in Sage.

RBC Capital analyst Shagun Singh said the deal fit strategically into J&J's neurological drugs division, an important area for the company. Sales of J&J's neurological drugs But at least one ...

Tenvie Therapeutics has unveiled with $200 million and the goal of transforming the neurological treatment landscape, nabbing several programs—and an executive—from Denali Therapeutics.

(Reuters) - Johnson & Johnson said on Monday it would buy neurological drug maker Intra-Cellular Therapies for $14.6 billion, its biggest deal in more than two years, boosting its presence in the ...